People | January 05, 2022
Dr. K.V.S Ram Rao is the new JMD & CEO of Granules India
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
The current annual U.S. market for amphetamine mixed salts, USP 1.25mg, 1.875mg, 2.5mg, 3.125mg, 3.75mg, 5mg, 7.5mg immediate release tablets strengths is approximately US $ 335 million, according to MAT, Oct 2021 IQVIA/IMS Health
Covaxin has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Neutralizing antibodies in children on an average 1.7 times higher than in adults
It will be marketed under the brand name Molunamax
The current annual U.S. market for prazosin hydrochloride 1mg, 2mg, 5mg strengths is approximately US $ 54 million, according to IQVIA/IMS Health
It plans to deliver over 300 million doses to the Indian government
DCGI approved the drug based on the review of clinical data
Molnupiravir is an orally administered form of a potent ribonucleoside analog that inhibits the replication of SARS-CoV-2
The company will market it under the brand name Molflu
The company has developed the API in house at its R&D center in Hyderabad
Subscribe To Our Newsletter & Stay Updated
